Literature DB >> 18159057

Incidence and prognosis of transient neurological attacks.

Michiel J Bos1, Marie Josee E van Rijn, Jacqueline C M Witteman, Albert Hofman, Peter J Koudstaal, Monique M B Breteler.   

Abstract

CONTEXT: Transient neurological attacks (TNAs) are attacks with temporary (<24 hours) neurological symptoms. These symptoms can be focal, nonfocal, or a mixture of both. The prognostic significance of TNAs with focal symptoms (better known as transient ischemic attacks [TIAs]) is well understood. Conversely, hardly anything is known about the prognostic significance of TNAs with nonfocal or mixed symptoms.
OBJECTIVE: To study the incidence and prognosis of focal TNAs (or TIAs), nonfocal TNAs, and mixed TNAs. DESIGN, SETTING, AND PARTICIPANTS: The study population comprised 6062 community-dwelling Rotterdam Study participants who were aged 55 years or older and free from stroke, myocardial infarction, and dementia at baseline (1990-1993). They were followed up for events until January 1, 2005. We analyzed the associations between incident TNAs and subsequent adverse events with age- and sex-adjusted Cox regression models. MAIN OUTCOME MEASURES: Stroke, ischemic heart disease, or dementia.
RESULTS: During 60 535 person-years, 548 participants developed TNA (282 focal, 228 nonfocal, and 38 mixed). The incidence rate per 1000 person-years was 4.7 (95% confidence interval [CI], 4.1-5.2) for focal TNA, 3.8 (95% CI, 3.3-4.3) for nonfocal TNA, and 0.6 (95% CI, 0.4-0.9) for mixed TNA. Participants with focal TNA were at higher risk of subsequent stroke than participants without TNA (n = 46 vs 540; hazard ratio [HR], 2.14; 95% confidence interval [CI]; 1.57-2.91) but had an equal risk of ischemic heart disease and dementia. Nonfocal TNA patients were at higher risk of stroke (27 vs 540; HR, 1.56; 95% CI, 1.08-2.28) and dementia (30 vs 552; HR, 1.59; 95% CI, 1.11-2.26) than participants without TNA. Mixed TNA patients were at higher risk of stroke (6 vs 540; HR, 2.48; 95% CI, 1.11-5.56), ischemic heart disease (8 vs 779; HR, 2.26; 95% CI, 1.07-4.78), vascular death (8 vs 594; HR, 2.54; 95% CI, 1.31-4.91), and dementia (7 vs 552; HR, 3.46; 95% CI, 1.72-6.98) than participants without TNA.
CONCLUSION: Patients who experience nonfocal TNAs, and especially those with mixed TNAs, have a higher risk of major vascular diseases and dementia than persons without TNA.

Entities:  

Mesh:

Year:  2007        PMID: 18159057     DOI: 10.1001/jama.298.24.2877

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  36 in total

1.  Ischemic transient neurological events identified by immune response to cerebral ischemia.

Authors:  Glen C Jickling; Xinhua Zhan; Boryana Stamova; Bradley P Ander; Yingfang Tian; Dazhi Liu; Shara-Mae Sison; Piero Verro; S Claiborne Johnston; Frank R Sharp
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

2.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

3.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

Review 4.  Diagnosis and Management of Transient Ischemic Attack.

Authors:  Shelagh B Coutts
Journal:  Continuum (Minneap Minn)       Date:  2017-02

5.  Recognition and management of transient ischaemic attack in primary care.

Authors:  Daniel Lasserson
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

6.  Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study.

Authors:  Catherine E de Keyser; Maarten J G Leening; Silvana A Romio; J Wouter Jukema; Albert Hofman; M Arfan Ikram; Oscar H Franco; Theo Stijnen; Bruno H Stricker
Journal:  Eur J Epidemiol       Date:  2014-09-12       Impact factor: 8.082

7.  Symptomatic and asymptomatic intracranial atherosclerotic stenosis: 3 years' prospective study.

Authors:  Urs Fischer; Kety Hsieh-Meister; Frauke Kellner-Weldon; Aikaterini Galimanis; Xin Yan; Johannes Kaesmacher; Marwan El-Koussy; Simon Jung; Marcel Arnold; Patrik Michel; Roland Wiest; Heinrich P Mattle; Jan Gralla; Mirjam R Heldner
Journal:  J Neurol       Date:  2020-02-25       Impact factor: 4.849

8.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

9.  Short-term and long-term risk of incident ischemic stroke after transient ischemic attack.

Authors:  Evan L Thacker; Kerri L Wiggins; Kenneth M Rice; W T Longstreth; Joshua C Bis; Sascha Dublin; Nicholas L Smith; Susan R Heckbert; Bruce M Psaty
Journal:  Stroke       Date:  2009-12-03       Impact factor: 7.914

Review 10.  Vascular dementia: a review of recent evidence for prevention and treatment.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.